Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
RXRXthis companyRecursion Pharmaceuticals, Inc.	$3.82	-2.84×	1.62×	24.5×	-2.08×	-318.1%	-62.0%	-867.9%	-863.4%	-57.0%	-48.1%	-20.7%	0.07×	1.19×	-358.08×	5.5×	0.0%	4	0.79	2	C
DNLIDenali Therapeutics Inc.	$19.98	-5.56×	2.86×	0×	-5.48×	-94.9%	0.0%	0.0%	0.0%	-50.6%	-52.6%	-14.6%	0.04×	0.34×	0×	9.16×	0.0%	3	2.05	2	C
MAZEMaze Therapeutics, Inc.	$34.25	-13.58×	5.02×	0×	-12.54×	-87.4%	0.0%	0.0%	0.0%	-36.9%	-37.7%	-6.3%	0.07×	1.29×	0×	15.5×	0.0%	3	11.54	2	C
RLAYRelay Therapeutics, Inc.	$19.93	-5.25×	2.56×	94.54×	-5.13×	-104.1%	76.8%	-1971.6%	-1800.6%	-48.8%	-50.5%	-16.2%	0.06×	0.19×	0×	22.61×	0.0%	3	26.32	2	C
Peer median	—	-5.56×	2.86×	0×	-5.48×	-94.9%	0.0%	0.0%	0.0%	-48.8%	-50.5%	-14.6%	0.06×	0.34×	0×	15.5×	0.0%	3	11.54	2	—